Skip to main content
Clinical Trials/IRCT20210613051561N1
IRCT20210613051561N1
Not yet recruiting
Phase 2

Comparative study of the frequency of complications due to high-risk pulmonary thromboembolism after rapid performance of the team responsible for pulmonary embolism (TIMAR) compared to conventional performance

Esfahan University of Medical Sciences0 sites74 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Pulmonary embolism.
Sponsor
Esfahan University of Medical Sciences
Enrollment
74
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age 18 to 75 years old
  • Diagnosis of pulmonary thromboembolism based on the GENEVA criteria
  • Patients with high\-risk pulmonary embolism
  • Satisfaction with entering this study

Exclusion Criteria

  • Dissatisfaction to continue participation in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials